[go: up one dir, main page]

ES2048646B1 - PROCEDURE FOR THE OBTAINING OF AFRICAN EQUINE PLASTER VIRUS PROTEIN VP2 (AHSV) - Google Patents

PROCEDURE FOR THE OBTAINING OF AFRICAN EQUINE PLASTER VIRUS PROTEIN VP2 (AHSV)

Info

Publication number
ES2048646B1
ES2048646B1 ES9200822A ES9200822A ES2048646B1 ES 2048646 B1 ES2048646 B1 ES 2048646B1 ES 9200822 A ES9200822 A ES 9200822A ES 9200822 A ES9200822 A ES 9200822A ES 2048646 B1 ES2048646 B1 ES 2048646B1
Authority
ES
Spain
Prior art keywords
obtaining
ahsv
procedure
african
plaster
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9200822A
Other languages
Spanish (es)
Other versions
ES2048646A1 (en
Inventor
Olmo Carmen Vela
Alvarez Jose Ignacio Casal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inmunologia y Genetica Aplicada SA
Original Assignee
Ercros SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ercros SA filed Critical Ercros SA
Priority to ES9200822A priority Critical patent/ES2048646B1/en
Publication of ES2048646A1 publication Critical patent/ES2048646A1/en
Application granted granted Critical
Publication of ES2048646B1 publication Critical patent/ES2048646B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE LA PROTEINA VP2 DEL VIRUS DE LA PESTE EQUINA AFRICANA (AHSV). EL PROCEDIMIENTO COMPRENDE EN UNA PRIMERA FASE OBTENER UNA MOLECULA DE CDNA QUE CODIFICA PARA LA SECUENCIA COMPLETA DE LA PROTEINA VP2 MEDIANTE EL DISEÑO DE OLIGONUCLEOTIDOS ESPECIFICOS PARA LAS REGIONES TERMINALES DEL GEN DE LA VP2 Y POSTERIORMENTE SINTETIZAR LA MOLECULA DE CDNA DE LONGITUD COMPLETA. EN UNA SEGUNDA FASE SE OBTIENEN LAS PROTEINAS VP2 RECOMBINANTES POR EXPRESION DE DICHA MOLECULA DE CDNA EN SISTEMAS ADECUADOS TALES COMO BACULOVIRUS MULTIPLICADOS EN CELULAS DE INSECTOS. LAS PROTEINAS VP2 RECOMBINANTES OBTENIDAS PUEDEN UTILIZARSE EN LA FORMULACION DE VACUNAS PARA PROTEGER EQUINOS CONTRA LA INFECCION CAUSADA POR AHSV Y TAMBIEN PUEDEN UTILIZARSE PARA DETECTAR LA PRESENCIA DE DICHO VIRUS EN ANIMALES SOSPECHOSOS DE ESTAR INFECTADOS POR AHSV.PROCEDURE FOR THE OBTAINING OF PROTEIN VP2 FROM AFRICAN AFRICAN PLAGUE VIRUS (AHSV). THE PROCEDURE INCLUDES IN A FIRST PHASE OBTAINING A CDNA MOLECULE THAT CODES FOR THE COMPLETE SEQUENCE OF THE VP2 PROTEIN THROUGH THE DESIGN OF SPECIFIC OLIGONUCLEOTIDE REGIONS FOR THE COMPLETE REGULATION OF THE COMPLETE CDOL GENE OF THE MOLUTE IN A SECOND PHASE, RECOMBINANT VP2 PROTEINS ARE OBTAINED BY EXPRESSION OF SUCH CDNA MOLECULA IN SUITABLE SYSTEMS SUCH AS BACULOVIRUS MULTIPLICATED IN INSECT CELLS. RECOMBINANT VP2 PROTEINS OBTAINED MAY BE USED IN THE FORMULATION OF VACCINES TO PROTECT EQUINE AGAINST AHSV INFECTION AND MAY ALSO BE USED TO DETECT THE PRESENCE OF SUCH VIRUSES IN SUSPECTED ANIMALS.

ES9200822A 1992-04-15 1992-04-15 PROCEDURE FOR THE OBTAINING OF AFRICAN EQUINE PLASTER VIRUS PROTEIN VP2 (AHSV) Expired - Fee Related ES2048646B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9200822A ES2048646B1 (en) 1992-04-15 1992-04-15 PROCEDURE FOR THE OBTAINING OF AFRICAN EQUINE PLASTER VIRUS PROTEIN VP2 (AHSV)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9200822A ES2048646B1 (en) 1992-04-15 1992-04-15 PROCEDURE FOR THE OBTAINING OF AFRICAN EQUINE PLASTER VIRUS PROTEIN VP2 (AHSV)

Publications (2)

Publication Number Publication Date
ES2048646A1 ES2048646A1 (en) 1994-03-16
ES2048646B1 true ES2048646B1 (en) 1994-10-01

Family

ID=8276762

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9200822A Expired - Fee Related ES2048646B1 (en) 1992-04-15 1992-04-15 PROCEDURE FOR THE OBTAINING OF AFRICAN EQUINE PLASTER VIRUS PROTEIN VP2 (AHSV)

Country Status (1)

Country Link
ES (1) ES2048646B1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE78293T1 (en) * 1983-05-27 1992-08-15 Texas A & M Univ Sys METHOD OF GENERATING A RECOMBINANT BACULOVIRUS EXPRESSION VECTOR.
AU4197389A (en) * 1988-08-05 1990-03-05 Mount Sinai School Of Medicine Of The City University Of New York, The In vivo infection of live insects with a recombinant baculovirus
GB2228486A (en) * 1989-02-27 1990-08-29 Univ Ottawa Improved baculovirus expression system capable of producing foreign gene proteins at high levels
NL8902301A (en) * 1989-09-14 1991-04-02 Rijksuniversiteit HUMAN PARVOVIRUS B19 PROTEINS, THEIR PRODUCTION AND THEIR USE IN DIAGNOSTIC ASSAYS AND VACCINES.

Also Published As

Publication number Publication date
ES2048646A1 (en) 1994-03-16

Similar Documents

Publication Publication Date Title
RU95115239A (en) Erythropoietin analog
AR003425A1 (en) RECOMBINANT MAPACHE POXVIRUS, VACCINE FOR USE IN CATS AND USE OF POXVIRUS TO PREPARE A VACCINE USEFUL TO AVOID OR DECREASE THE DISEASE CAUSED BY THE FELINE IMMUNODEFICIENCY VIRUS (IVF)
ES2134022T3 (en) COSMETIC COMPOSITIONS BASED ON MULTI-SEQUENCED IONIZABLE POLYCONDENSATES POLYSILOXANE / POLYURETHANE AND / OR POLYUREA IN SOLUTION AND UTILIZATIONS.
AR008727A1 (en) COMPOSITIONS AND MELTING PROTEINS INCLUDING A POLYPEPTIDE INCLUDING AN IMMUNOGENIC PORTION OF A PROSTATE PROTEIN OR ITS VARIANT, AND USES THEREOF TO PREPARE A MEDICINAL PRODUCT
PE20081686A1 (en) FUSION PROTEINS INCLUDING AN ANTIGEN PRAME (DAGE)
ES2059547T3 (en) IMPROVED EXPRESSION AND SECRETION OF HETEROLOGICAL PROTEINS IN YEAST, USING CONDUCTING SEQUENCE OF TRUNCATED ALPHA FACTOR.
MX9204685A (en) DNA SEQUENCE CODING AN EXTERNAL SURFACE PROTEIN (OSPA) OR DERIVED FROM THE SAME VACCINE COMPOSITION QE INCLUDES SUCH PROTEIN.
ES2032802T3 (en) BLOOD SUBSTITUTE, SEMI-SYNTHETIC, EXTRAPURE.
CY1105763T1 (en) GLYCOPROTEIN HORMONE ANALOGUES OF DISULFIDE CROSS-LINKING, THEIR PREPARATION AND USE
PE43298A1 (en) SYNTHETIC GENES OF HIV
EP1521594A4 (en) ENDOGENOUS RETROVIRUS POLYPEPTIDES RELATED TO ONCOGENIC TRANSFORMATION
ATE365749T1 (en) HUMAN PEPTIDES/PROTEINS THAT CAUSE OR EFFECT THE KILLING OF CELLS, INCLUDING LYMPHOID TUMOR CELLS
AR248045A1 (en) Recombinant avipox virus
ES2115622T5 (en) MOLECULAR CLONES OF HIV-1 AND USES OF THE SAME.
AR003135A1 (en) RECOMBINANT BACULOVIRUSES, A VACCINE THAT CONTAINS THEM, AND THE USE OF THE SAME TO PREPARE A VACCINE USEFUL TO AVOID OR DECREASE THE DISEASE CAUSED BY FELINE IMMUNODEFICIENCY VIRUSES.
BR0206852A (en) Neublastin polymer conjugates and methods for using them
ATE474850T1 (en) ANALOGUES OF PEPTIDES OF THE RELAXIN SUPERFAMILY
PE20050197A1 (en) ANTI-DENGUE VIRUS ANTIBODIES, COMPOSITIONS, METHODS AND USES
AR002742A1 (en) ADIPOSE TYPE REGULATORY PROTEIN, PROCEDURE TO PRODUCE SUCH PROTEIN, PHARMACEUTICAL FORMULATIONS INCLUDING IT, ISOLATED DNA MOLECULES THAT CODES SUCH PROTEIN, VECTOR AND RECOMBINANT CELLS THAT INCLUDE SUCH DNA
AR018489A1 (en) USE OF A GENETICALLY PERFORMED CELL THAT INCLUDES DNA CODIFYING A TRANSMEMBRANE AND PROTEIN LYMPHOCATE ACTIVATION GENE PROTEIN 3 (LAG-3) FOR THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT TO INDICATE THE PROTECTION OF MISCELLENT RETIREMENT AND USE OF THE SAME
DK1635776T5 (en) Lipid transfer protein systems as well as their cosmetic dermatological application
AR010565A1 (en) ISOLATED NUCLEIC ACID MOLECULES, ISOLATED PROTEIN, FORMULATIONS CONTAINING THEM, THERAPEUTIC COMPOSITION, USE OF A PROTECTIVE COMPOUND AND ANINHIBITOR TO PREPARE A COMPOSITION OF TREATMENT, IDEAL COMPOSITION, A CARBOIL PROTEIN,
ES2048646B1 (en) PROCEDURE FOR THE OBTAINING OF AFRICAN EQUINE PLASTER VIRUS PROTEIN VP2 (AHSV)
ATE284222T1 (en) MODIFIED PROTEINS AND THEIR USE FOR CONTROLLING VIRUS INFECTIONS
BR112022026248A2 (en) CYTOKINE CONJUGATES

Legal Events

Date Code Title Description
PC2A Transfer of patent

Owner name: INMUNOLOGIA Y GENETICA APLICADA, S.A.

FD2A Announcement of lapse in spain

Effective date: 20180806